Kaplan-Meier survival analysis of TCGA data also indicated that overall survival was significantly lower in lung cancer patients with hypermethylation of PRKCDBP than in patients with hypomethylation of PRKCDBP (P=0.012, Fig 4D). The gene discussed is CAVIN3; the disease is lung carcinoma.